Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Novo Nordisk Inc.
Current Parent Company: Novo Holdings A/S
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $1,100,000
Year: 2017
Date: September 5, 2017
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: drug or medical equipment safety violation
Violation Description: The California Insurance Commissioner reached a $1.1 million settlement with pharmaceutical company Novo Nordisk Inc. over allegations that Novo Nordisk's drug Victoza was extensively promoted for uses not approved of by the Food and Drug Administration, a violation of the Insurance Frauds Prevention Action.
Level of Government: state
Action Type: agency action
Agency: California Department of Insurance
Civil or Criminal Case: civil
Facility State: California
HQ Country of Current Parent: Denmark
Ownership Structure of Current Parent: privately held
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.